1. Ning B, Zhang M, Su N, Bur R, Ma H, Liu K, et al. Global, regional, and National burden of polycystic ovary syndrome, 1990–2021: a comprehensive analysis of trends and projections based on the global burden of disease 2021 study. Gynecological Endocrinology 2025; 41(1):2535737.
2. Naz MS, Tehrani FR, Majd HA, Ahmadi F, Ozgoli G, Fakari FR, et al. The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis. International journal of reproductive biomedicine 2019; 17(8):533.
3. Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. Journal of clinical medicine 2023; 12(4):1454.
4. Torkashvand H, Shabani R, Artimani T, Pilehvari S, Moghimi M, Torkashvand L, et al. Enhancing oocyte competence in patients with polycystic ovarian syndrome: A microfluidic study on the effects of follicular fluid meiosis‐activating sterol in in vitro oocyte maturation. Journal of Obstetrics and Gynaecology Research 2025; 51(1): e16203.
5. Bansal B, Kishore AT, Kathiresan S, Ghachi AF, Pradhan S, Paul S, et al. A systematic review of inflammatory markers in polycystic ovary syndrome (PCOS) and meta-analysis of interleukin-6 (IL-6) in case-control studies. Cureus 2025; 17(4).
6. Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, et al. Chronic low-grade inflammation in pathogenesis of PCOS. International journal of molecular sciences 2021; 22(7):3789.
7. Arabipoor A, Hasani F, Hafezi M, Irani S, Hosseini R, Nasiri N, et al. Global perspective on the diagnosis and treatment of polycystic ovary syndrome: a narrative review of different clinical guidelines. Iran J Obstet Gynecol Infertil 2025; 28(8):68-83.
8. Behmard V, Hadizadeh-Talasaz F, Pishvaee M, Khajavian N, Rahmani Beilandi R. The effect of Vitex Agnus-Castus pill on follicles number and size in infertile women with polycystic ovary syndrome: A triple-blind placebo randomized clinical trial. The Iranian Journal of Obstetrics, Gynecology and Infertility 2022; 25(6):98-106.
9. Arefhosseini S, Roshanravan N, Asghari S, Tutunchi H, Ebrahimi-Mameghani M. Expression of inflammatory genes, WBC-derived inflammatory biomarkers and liver function indices: Effects of myo-inositol supplementation in obese patients with NAFLD. Journal of functional foods 2023; 104:105524.
10. Greff D, Juhász AE, Vancsa S, Varadi A, Sipos Z, Szinte J, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology 2023; 21(1):10.
11. Jamilian M, Farhat P, Foroozanfard F, Afshar Ebrahimi F, Aghadavod E, Bahmani F, et al. Expression of concern: comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: a randomized controlled clinical trial. Clinical endocrinology 2017; 87(2):194-200.
12. De Diego MV, Gómez-Pardo O, Groar JK, López-Escobar A, Martín-Estal I, Castilla-Cortázar I, et al. Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study. Archives of gynecology and obstetrics 2020; 302(5):1169-79.
13. Colazingari S, Treglia M, Najjar R, Bevilacqua A. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Archives of Gynecology and Obstetrics 2013; 288(6):1405-11.
14. Showell MG, Mackenzie‐Proctor R, Jordan V, Hodgson R, Farquhar C. Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2018(12).
15. Lesoine B, Regidor PA. Prospective randomized study on the influence of myoinositol in PCOS women undergoing IVF in the improvement of oocyte quality, fertilization rate, and embryo quality. International journal of endocrinology 2016; 2016(1):4378507.
16. Deng H, Chen Y, Xing J, Zhang N, Xu L. Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome. Frontiers in immunology 2024; 15:1470283.
17. Orisaka M, Mizutani T, Miyazaki Y, Shirafuji A, Tamamura C, Fujita M, et al. Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging. Frontiers in endocrinology 2023; 14:1324429.
18. Papaleo ME, Unfer MV, Baillargeon MJ, Fusi MF, Occhi MF, De Santis BS. RETRACTED: Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril 2009; 91(5):1750-4.
19. Attia GM, Almouteri MM, Alnakhli FT, Almouteri M, Alnakhli F. Role of metformin in polycystic ovary syndrome (PCOS)-related infertility. Cureus 2023; 15(8).
20. Bizzarri M, Monti N, Piombarolo A, Angeloni A, Verna R. Myo-inositol and D-chiro-inositol as modulators of ovary steroidogenesis: a narrative review. Nutrients 2023; 15(8):1875.
21. Kamenov Z, Kolarov G, Gateva A, Carlomagno G, Genazzani AD. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecological Endocrinology 2015; 31(2):131-5.
22. Kutenaei MA, Teshnizi SH, Ghaemmaghami P, Eini F, Roozbeh N. The effects of myo-inositol vs. metformin on the ovarian function in the polycystic ovary syndrome: a systematic review and meta-analysis. European Review for Medical & Pharmacological Sciences 2021; 25(7):3105.